Penserra Capital Management LLC Replimune Group, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$25.43 - $34.25 $27,210 - $36,647	-1,070 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$28.98 - $39.54 $289 - $395	10 Added 0.94%	1,070 $31,000
Q2 2021 Aug 12, 2021	BUY	$28.5 - $39.37 $285 - $393	10 Added 0.95%	1,060 $40,000
Q1 2021 May 13, 2021	SELL	$30.22 - $45.57 $151 - $227	-5 Reduced 0.47%	1,050 $32,000
Q4 2020 Feb 12, 2021	BUY	$23.5 - $52.65 $24,792 - $55,545	1,055 New	1,055 $40,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $631M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.